-
Signature
-
Kaushik Ghoshal, Chief Commercial Officer, SaaS business
-
Issuer symbol
-
RMD
-
Transactions as of
-
03 Mar 2025
-
Net transactions value
-
-$478,405
-
Form type
-
4
-
Filing time
-
04 Mar 2025, 17:25:40 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$77,716 |
+367 |
+3.8% |
$211.76 |
10,092 |
03 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$513,068 |
+3,506 |
+35% |
$146.34 |
13,598 |
03 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$75,219 |
+514 |
+3.8% |
$146.34 |
14,112 |
03 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$1,000,778 |
+4,726 |
+33% |
$211.76 |
18,838 |
03 Mar 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$86,336 |
-367 |
-1.9% |
$235.25 |
18,471 |
03 Mar 2025 |
Direct |
F1, F2 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$825,308 |
-3,506 |
-19% |
$235.40 |
14,965 |
03 Mar 2025 |
Direct |
F1, F2 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$120,918 |
-514 |
-3.4% |
$235.25 |
14,451 |
03 Mar 2025 |
Direct |
F1, F2 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$1,112,624 |
-4,726 |
-33% |
$235.43 |
9,725 |
03 Mar 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-367 |
-78% |
$0.000000 |
105 |
03 Mar 2025 |
ResMed Common Stock |
367 |
$211.76 |
Direct |
F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-3,506 |
-49% |
$0.000000 |
3,589 |
03 Mar 2025 |
ResMed Common Stock |
3,506 |
$146.34 |
Direct |
F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-514 |
-75% |
$0.000000 |
169 |
03 Mar 2025 |
ResMed Common Stock |
514 |
$146.34 |
Direct |
F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-4,726 |
-45% |
$0.000000 |
5,882 |
03 Mar 2025 |
ResMed Common Stock |
4,726 |
$211.76 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: